                               SEQUENCE LISTING

<110> GEORGETOWN UNIVERSITY
 
<120> USE OF INHIBITORS OF YAP/TAZ FOR THE TREATMENT OF CANCER

<130> A376-62.1.WO

<140> PCT/US2020/030001
<141> 2020-04-26

<150> 62/844,117
<151> 2019-05-06

<150> 62/843,559
<151> 2019-05-05

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
gtgccaccaa gctagataaa ga                                                22


<210> 2
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
ggcatcttgg tccaggaaat gt                                                22


<210> 3
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
tgctgtctcc atgtttgatg tatct                                             25


<210> 4
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
tctctgctcc ccacctctaa gt                                                22


<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
cacccaagaa cagggtttgt                                                   20


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
tggccatggg tatgttgtta                                                   20


